Around the DOC News February 21, 2024
advertisement
- Hospitalized Children With Diabetes May Be Able to Continue Safe Use of Home Pumps, Suggest Findings
- Spike hype
- As technology improves, increasing CGM access requires education, community support
- Rising medication costs pose barrier to diabetes treatment, study finds
- Diabetes Dialogue: Tirzepatide in Type 1 Diabetes, with Viral Shah, MD
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
- Patients With Type 1 Diabetes Not Achieving Glycemic Targets Despite Use of New Technology
- Immunotherapy to treat people with type 1 diabetes genotype granted fast track designation
- Helmsley Charitable Trust Awards Over $12 Million to Projects Aimed at Helping People With Type 1 Diabetes Safely Incorporate Exercise Into Their Daily Lives
- What’s New in the 2024 ADA Standards of Care?
- Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care
- Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis
- Type 1 Diabetes Onset Tied to Decreased Complement Protein Levels
- FDA fast tracks Diamyd’s immunotherapy for managing type 1 diabetes
- JDRF Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection
